EUVIMEDEUVIMED entdecken
Crossref

Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure

Eugene S J Tan, Siew-Pang Chan, Yeunhyang C Choi, Chris J Pemberton, Richard Troughton, Katrina Poppe, Mayanna Lund, Gerry Devlin, Robert N Doughty, A Mark Richards

JACC: Heart Failure · 2023

DOI: 10.1016/j.jchf.2023.01.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Heart Failure, 2023. Verfasst von Eugene S J Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National University Heart Centre, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University S…. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Regional handling and the prognostic performance of insulin-like growth factor binding protein (IGFBP)-7, in contrast or in combination with other candidate biomarkers, in chronic heart failure (CHF) remain uncertain. OBJECTIVES: The authors investigated the regional handling of plasma IGFBP-7 and its association with long-term outcomes in CHF in comparison with selected circulating biomarkers. METHODS: Plasma concentrations of IGFBP-7, N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity troponin-T, growth differentiation factor-15, and high-sensitivity C-reactive protein were measured prospectively in a cohort with CHF (n = 863). The primary outcome was the composite of heart failure (HF) hospitalization or all-cause mortality. In a separate non-HF cohort (n = 66) undergoing cardiac catheterization, transorgan gradients of plasma IGFBP-7 concentrations were evaluated. RESULTS: Among 863 patients (age 69 ± 14 years, 30% female, 36% HF with preserved ejection fraction), IGFBP-7 (median: 121 [IQR: 99-156] ng/mL) related inversely to left ventricular volumes but directly to diastolic function. Above the optimal cutoff, IGFBP-7 ≥110 ng/mL was independently associated with 32% increased hazard of the primary outcome: 1.32 (95% CI: 1.06-1.64). Among the 5 markers, IGFBP-7 had the highest hazard for a proportional increment in plasma concentrations independent of HF phenotype in single- and double-biomarker models, and provided incremental prognostic value beyond clinical predictors plus NT-proBNP, high-sensitivity troponin-T, and high-sensitivity C-reactive protein (P < 0.05). Assessment of regional concentrations indicated renal secretion of IGFBP-7 in contrast to renal extraction of NT-proBNP, possible cardiac extraction of IGFBP-7 in contrast to secretion of NT-proBNP, and common hepatic extraction of both peptides. CONCLUSIONS: Transorgan regulation of IGFBP-7 is distinct from NT-proBNP. Circulating IGFBP-7 independently predicts adverse outcomes in CHF with a strong prognostic performance when compared with other well-recognized cardiac-specific or noncardiac prognostic markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureFemaleHumansMaleBiomarkersC-Reactive ProteinChronic DiseaseInsulin-Like Growth Factor Binding ProteinsNatriuretic Peptide, BrainPeptide FragmentsPrognosisStroke VolumeTroponin TMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

biomarkersheart failureinsulin-like growth factor binding protein (IGFBP)-7prognosis

Substanzen

BiomarkersC-Reactive Proteininsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding ProteinsNatriuretic Peptide, BrainPeptide FragmentsTroponin T

Autor:innen und Institutionen

  • Department of Cardiology, National University Heart Centre, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore.
  • Section of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.
  • Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
  • Heart Health Research Group, University of Auckland, Auckland, New Zealand; Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.
  • Department of Cardiology, Middlemore Hospital, Auckland, New Zealand.
  • Department of Cardiology, Gisborne Hospital, Gisborne, New Zealand.

Zitieren

APA

Tan, E. S. J., Chan, S. P., Choi, Y. C., Pemberton, C. J., Troughton, R., Poppe, K., Lund, M., Devlin, G., Doughty, R. N., & Richards, A. M. (2023). Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.01.016

Vancouver

Tan ESJ, Chan SP, Choi YC, Pemberton CJ, Troughton R, Poppe K, et al. Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure. JACC: Heart Failure. 2023. doi:10.1016/j.jchf.2023.01.016

BibTeX
@article{Tan2023,
  author = {Tan, Eugene S J and Chan, Siew-Pang and Choi, Yeunhyang C and Pemberton, Chris J and Troughton, Richard and Poppe, Katrina and Lund, Mayanna and Devlin, Gerry and Doughty, Robert N and Richards, A Mark},
  title = {Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure},
  journal = {JACC: Heart Failure},
  year = {2023},
  doi = {10.1016/j.jchf.2023.01.016}
}
Kostenlos starten →